医学
2型糖尿病
糖尿病
葡萄糖稳态
糖原发生
糖异生
二甲双胍
药理学
内科学
内分泌学
生物信息学
糖原
生物
胰岛素抵抗
糖原合酶
新陈代谢
作者
Sachin Sharma,Manjusha Choudhary,Vikas Budhwar
出处
期刊:Current Diabetes Reviews
[Bentham Science]
日期:2022-11-01
卷期号:18 (9)
被引量:1
标识
DOI:10.2174/1573399818666220210140745
摘要
Diabetes mellitus is the most prevalent malady, becoming a leading public health concern around the world. It is a chronic endocrine metabolic disturbance that is accompanied with the commencement of a sequence of complications. The liver primarily serves as the body's glucose or fuel reserve and also maintains standard blood sugar concentration. Hepatic gluconeogenesis, glycolysis and glycogenesis are the key contributors to fasting or post-prandial hyperglycaemia in type 2 diabetes mellitus subjects. So, regulating these channels could be a viable approach for mitigating the hyperglycaemia in type 2 diabetes mellitus. Few potential synthetic drugs that precisely target hepatic glucose-producing metabolic pathways are presently available but they have some serious negative effects like hypoglycaemia, hepatosteatosis and lactic acidosis. Therefore, scientists have veered to herbal products because of their edible nature, cost-effectiveness and fewer side effects. Natural products and their isolated phytochemicals are progressively being employed to manage hyperglycaemia by modulating the enzyme's activity and regulating transcription factors concerned with hepatic glucose synthesis. We reviewed the potential effects of isolated bioactive phytochemicals on interesting targets that affect hepatic glucose homeostasis in diabetes. This study illustrates the benefit and feasibility of developing liver-specific drugs through secondary metabolites to restore hyperglycaemia.
科研通智能强力驱动
Strongly Powered by AbleSci AI